Serap Yavuz
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients. (NCT06223932) | Serap Yavuz | 2022-07-07 |
Track Serap Yavuz automatically
Every clearance here is in the API, with alerts when new ones post.